Vedran Radojcic

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Venues

Blood

The New England journal of medicine

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Bone marrow transplantation

University of Utah

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Utah

United States

Assistant Professor :: Internal medicine

University of Michigan Jul 01 2015 - Sep 02 2016

United States

Clincal lecturer :: Internal medicine

University of Michigan Jun 27 2009 - Jun 30 2015

United States

House officer :: Internal medicine

Publications

Daniel Wolff, Corey S Cutler, Stephanie J Lee, Iskra Pusic, Henrique Bittencourt, Jennifer White, Mehdi Hamadani, Sally Arai, Amandeep Salhotra, Jose A Perez-Simon, Amin Alousi, Hannah Choe, Mi Kwon, Arancha Bermúdez, Inho Kim, Gerard Socié, Saurabh Chhabra, Vedran Radojcic, Timothy O'Toole, Chuan Tian, Peter Ordentlich, Zachariah DeFilipp, Carrie L Kitko, null null
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease. The New England journal of medicine 391 (11) (2024)
Carrie L Kitko, Mukta Arora, Zachariah DeFilipp, Mohammad Abu Zaid, Antonio Di Stasi, Vedran Radojcic, Courtney B Betts, Lisa M Coussens, Michael L Meyers, Hope Qamoos, Peter Ordentlich, Vinit Kumar, Christine Quaranto, Aaron Schmitt, Yu Gu, Bruce R Blazar, Trent P Wang, Amandeep Salhotra, Iskra Pusic, Madan Jagasia, Stephanie J Lee
Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Vedran Radojcic, Maria Pletneva, Catherine J Lee, Sanja Ivcevic, Stefanie Sarantopoulos, Daniel Couriel
Hedgehog blockade in steroid-refractory sclerotic chronic graft-versus-host disease. British journal of haematology 195 (2) (2021)
Wei Jia, Jonathan C Poe, Hsuan Su, Sarah Anand, Glenn K Matsushima, Jeffrey C Rathmell, Ivan Maillard, Vedran Radojcic, Kazuhiro Imai, Nancy J Reyes, Diana M Cardona, Zhiguo Li, Amy N Suthers, Itaevia M Curry-Chisolm, Rachel A DiCioccio, Daniel R Saban, Benny J Chen, Nelson J Chao, Stefanie Sarantopoulos
BAFF promotes heightened BCR responsiveness and manifestations of chronic GVHD after allogeneic stem cell transplantation. Blood 137 (18) (2021)
Shannon Rose McCurdy, Vedran Radojcic, Hua-Ling Tsai, Ante Vulic, Elizabeth Thompson, Sanja Ivcevic, Christopher G Kanakry, Jonathan D Powell, Brian Keith Lohman, Djamilatou Adom, Sophie Paczesny, Kenneth R Cooke, Richard J Jones, Ravi Varadhan, Heather J Symons, Leo Luznik
Signatures of GVHD and Relapse after Post-Transplant Cyclophosphamide Revealed by Immune Profiling and Machine Learning. Blood (2021)
Vedran Radojcic, Leo Luznik
PTCy and "The Story of the Three Bears". Bone marrow transplantation 56 (4) (2020)
Vedran Radojcic, Leo Luznik
PTCY keeps on giving! Blood 134 (11) (2020)
Jooho Chung, Vedran Radojcic, Eric Perkey, Timothy J Parnell, Yashar Niknafs, Xi Jin, Ann Friedman, Nathalie Labrecque, Bruce R Blazar, Todd V Brennan, Christian W Siebel, Ivan P Maillard
Early Notch Signals Induce a Pathogenic Molecular Signature during Priming of Alloantigen-Specific Conventional CD4+ T Cells in Graft-versus-Host Disease. Journal of immunology (Baltimore, Md. : 1950) 203 (2) (2019)

Vedran Radojcic.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Vedran Radojcic